WA
RVMD icon

WPG Advisers’s Revolution Medicines RVMD Stock Holding History

WPG Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187 Buy
+1
New +$146 ﹤0.01% 1505
2025
Q1 		– Sell
-46
Closed -$2.01K – 1523
2024
Q4 		$2.01K Buy
+46
New +$2.32K ﹤0.01% 1077

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

WPG Advisers's RVMD Position: Q2 2026 in Review

WPG Advisers opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1 share worth $187. The stake represents ﹤0.01% of the portfolio and ranks #1505 among its holdings. This is a return to the name: WPG Advisers previously reported a position in RVMD as recently as Q4 2024.

WPG Advisers first reported a position in RVMD in Q4 2024 and has held it in 2 quarters since. The position peaked at $2.01K in Q4 2024. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • WPG Advisers held 1 share of Revolution Medicines worth $187 as of Q2 2026.
  • Revolution Medicines was a new WPG Advisers position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1505 holding.
  • WPG Advisers first reported a position in Revolution Medicines in Q4 2024 and has held it in 2 quarters since.
  • WPG Advisers's Revolution Medicines position peaked at $2.01K in Q4 2024.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.